This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

HYD - Hydrix Limited

HYD shareholders must be cheering today as the slow, grinding share price decline of the last ten months finally ends.



Buyers are piling into Hydrix today as FDA approval finally comes through for their Guardian device, paving the way for a commercial release of the implantable cardiac monitor in the USA. Huge market for this product. Let's see what HYX do with this opportunity.

The HYD share price has leapt 58% to 24.5c following this morning's announcement. Huge gap up.

 
May 2023 comp entry.
A little bottom feeding action here.
Not held and purely a random chart choice.
I guess my point is, in my opinion, it has a long shot of being a dark horse.

 
Interesting, looking at the two graphs, how the June 2021 spike just disappeared into nothingness,,.. a one day wonder (and to resume a slow, grinding share price decline)
 
Yarp, it doesn't pass my trading or investing rules, but they don't matter for a comp entry.
Not much cash left, they might be going cap in hand soon, although they have arranged a line of credit, probably at exorbitant interest rates.

"The variable interest rate is the bank bill swap rate (“BBSW”) plus a facility margin of 7.10% p.a. (an initial rate of 10.7834%, based on the current BBSW). Hydrix Services must also pay a Facility fee of 1.50% p.a."

Don't like my chances here. Fingers crossed for some good news.

 
wakey wakey


Hydrix International expansion strategy is succeeding
.
Wholly owned subsidiary, Hydrix Services, has entered into a $2.8m contract extension with leading European medical device company Paul Hartmann AG.

The contract extension represents a further stage of works that Hydrix Services will undertake for Hartmann, as part of a multi-stage product development program. Hydrix anticipates that the stage of works will be completed, and all $2.8m of revenue will be recognised, by the end of September 2025, adding to the $3.7m cumulative revenue from previous contract stages.

Alan Morris, Group Marketing Director, commented:
Winning this project stage highlights our dedication to excellence and innovation, strengthens our growing reputation in international markets, and advances our strategy of pursuing global opportunities."
 
Cookies are required to use this site. You must accept them to continue using the site. Learn more...